Transfection of a rearranged viral DNA fragment, WZhet, stably converts latent Epstein-Barr viral infection to productive infection in lymphoid cells.
about
Epstein-Barr virus reactivation after superinfection of the BJAB-B1 and P3HR-1 cell lines with cytomegalovirus.Distance and helical phase dependence of synergistic transcription activation in cis-regulatory moduleGenome rearrangements activate the Epstein-Barr virus gene whose product disrupts latency.The K-bZIP protein from Kaposi's sarcoma-associated herpesvirus interacts with p53 and represses its transcriptional activity.Detection of EBV, HBV, HCV, HIV-1, HTLV-I and -II, and SMRV in human and other primate cell linesGenetic dissection of cell growth arrest functions mediated by the Epstein-Barr virus lytic gene product, ZtaIdentification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virusSeparate cis-regulatory elements confer expression of phosphoenolpyruvate carboxykinase (GTP) gene in different cell linesEpstein-Barr virus mRNA export factor EB2 is essential for intranuclear capsid assembly and production of gp350Molecular virology of Epstein-Barr virus.Complete genomic sequence of an Epstein-Barr virus-related herpesvirus naturally infecting a new world primate: a defining point in the evolution of oncogenic lymphocryptoviruses.Sequence analysis of the Epstein-Barr virus (EBV) BRLF1 gene in nasopharyngeal and gastric carcinomas.The nuclear and adherent junction complex component protein ubinuclein negatively regulates the productive cycle of Epstein-Barr virus in epithelial cellsThe effect of Epstein-Barr virus Latent Membrane Protein 2 expression on the kinetics of early B cell infectionTerminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo.Epstein-Barr virus Zta upregulates matrix metalloproteinases 3 and 9 that synergistically promote cell invasion in vitro.Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1.Amino acids in the basic domain of Epstein-Barr virus ZEBRA protein play distinct roles in DNA binding, activation of early lytic gene expression, and promotion of viral DNA replication.Epithelial cell retention of transcriptionally active, P3HR-1-derived heterogeneous Epstein-Barr virus DNA with concurrent loss of parental virus.A survey of Epstein-Barr virus gene expression in sporadic non-Hodgkin's lymphomas. Detection of Epstein-Barr virus in a subset of peripheral T-cell lymphomas.YY1 binds to and regulates cis-acting negative elements in the Epstein-Barr virus BZLF1 promoter.Identification of cellular target genes of the Epstein-Barr virus transactivator Zta: activation of transforming growth factor beta igh3 (TGF-beta igh3) and TGF-beta 1The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitorsCharacterization of the ZI domains in the Epstein-Barr virus BZLF1 gene promoter: role in phorbol ester induction.X-box-binding protein 1 activates lytic Epstein-Barr virus gene expression in combination with protein kinase D.The Epstein-Barr virus BcRF1 gene product is a TBP-like protein with an essential role in late gene expression.Epstein-Barr virus lytic transactivator Zta enhances chemotactic activity through induction of interleukin-8 in nasopharyngeal carcinoma cells.Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B.DNA-binding-defective mutants of the Epstein-Barr virus lytic switch activator Zta transactivate with altered specificitiesA selectable marker allows investigation of a nontransforming Epstein-Barr virus mutantEpstein-Barr virus (EBV)-negative B-lymphoma cell lines for clonal isolation and replication of EBV recombinants.The Epstein-Barr virus (EBV) BZLF1 immediate-early gene product differentially affects latent versus productive EBV promoters.An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivatorsDefective viral DNA in Epstein-Barr virus-associated oral hairy leukoplakia.Levels of Epstein-Barr virus DNA in lymphoblastoid cell lines are correlated with frequencies of spontaneous lytic growth but not with levels of expression of EBNA-1, EBNA-2, or latent membrane protein.Identification of phorbol ester response elements in the promoter of Epstein-Barr virus putative lytic switch gene BZLF1The Epstein-Barr virus (EBV) BMRF1 promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell-specific manner.The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle.The Epstein-Barr virus immediate-early gene product, BMLF1, acts in trans by a posttranscriptional mechanism which is reporter gene dependent.The Epstein-Barr virus BMLF1 promoter contains an enhancer element that is responsive to the BZLF1 and BRLF1 transactivators
P2860
Q24798984-0A399B2E-CA33-4EAF-B026-B07218EC422FQ28732365-F464D6F6-EC3F-4BC8-B6C4-0083E21C29F4Q33688737-B946D9AB-00F1-455D-BFB1-87CA9BBD9436Q33813261-4467023F-C08F-40F9-BB16-F93EBD81478CQ33816682-58CE7CD8-DD36-4541-92C4-79E4E97B987BQ33822549-4AE2B857-C829-4055-99BF-75F7E156EF36Q33835632-A42937AF-71FC-4F25-8CC5-02C42C3B4E2FQ33836561-1A202CE9-0AFF-4846-98E2-D95E2E51E000Q34123899-49198826-7253-4DFF-B7EB-7C8DF976465EQ34225554-521A9D19-D8C9-435B-9662-18EA647D6AAFQ34360303-67733FF0-AF62-479F-A10F-41A7670CCA11Q34410536-38B6E615-1C21-4423-BD45-D49E01936A29Q34485205-C0CE615C-EC01-4949-AA31-727B795F6114Q34545445-9B036A54-9570-4D3E-96B8-7057A3C74F84Q34553645-B26AB451-3C4A-47F8-B71E-AE5037B3F018Q34586675-DA518F89-A043-4726-94EA-5B9B0F4C7E88Q34981036-E515C1A8-10B5-4209-8E60-7D9DDBF606DDQ35024349-564594EE-72A7-4698-A979-AE56F8FC919CQ35140295-8CA16B38-65E3-47C6-8758-F518BB52C0F1Q35831803-DD5C8492-F13C-454F-9578-B567822F284DQ35841116-576CA7C3-AD44-4A27-8FF8-AF263E111AB5Q35841284-CBD6E845-6525-4F63-9652-22670F51012AQ35851139-CF729424-0CF0-4F38-80C2-EBBE1C6F6E3EQ35861789-6746A1C6-F49D-4B30-9750-163FA787061FQ35914523-F214A360-E169-4406-8E22-B92F19D87633Q36023187-4EB9CD71-1FBE-44D5-839E-36855D67F02FQ36498181-1A51E8C3-CB29-43DC-86D4-9FA9A26126B9Q36651589-264B0C77-D1C0-451A-9FCB-DFD459035ABCQ36652041-EA7E5400-EA10-4134-B9D4-6D8742467292Q36697700-892CF22A-ACA4-40DA-A459-F054C65816FBQ36700868-16F7AA12-A952-4ADF-A11B-2F1E1A0A177AQ36792029-4475065D-65F0-403F-AA5B-6D20CCC8A611Q36799401-A93856F9-8C8B-48AF-AC30-818213F9D7AFQ36799631-315321A5-E81A-46A8-B4EB-2E86577100F9Q36799887-8A2929CF-3056-44FC-9BA1-2FB6159A5579Q36802259-D0211D42-BC86-4989-8042-5373B0B1C012Q36812174-390F5E22-D987-4B7D-8D1D-716DBB3AD03CQ36829427-FA08AFBA-0277-4164-9364-A5CB23B47E40Q36830488-C21D1831-202D-4985-ABBF-37AFDCD6BFADQ36830501-8DB87E02-8B4A-4361-932E-BA95018A5CA9
P2860
Transfection of a rearranged viral DNA fragment, WZhet, stably converts latent Epstein-Barr viral infection to productive infection in lymphoid cells.
description
1987 nî lūn-bûn
@nan
1987 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի մարտին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Transfection of a rearranged v ...... e infection in lymphoid cells.
@ast
Transfection of a rearranged v ...... e infection in lymphoid cells.
@en
Transfection of a rearranged v ...... e infection in lymphoid cells.
@nl
type
label
Transfection of a rearranged v ...... e infection in lymphoid cells.
@ast
Transfection of a rearranged v ...... e infection in lymphoid cells.
@en
Transfection of a rearranged v ...... e infection in lymphoid cells.
@nl
prefLabel
Transfection of a rearranged v ...... e infection in lymphoid cells.
@ast
Transfection of a rearranged v ...... e infection in lymphoid cells.
@en
Transfection of a rearranged v ...... e infection in lymphoid cells.
@nl
P2093
P2860
P356
P1476
Transfection of a rearranged v ...... ve infection in lymphoid cells
@en
P2093
P2860
P304
P356
10.1073/PNAS.84.5.1332
P407
P50
P577
1987-03-01T00:00:00Z